Delian Capital Overview

  • Investor Type
  • Venture Capital
  • Investments
  • 67
  • Portfolio
  • 53
  • Exits
  • 9
Exits

Delian Capital General Information

Description

Founded in 2011, Delian Capital is an early and growth stage venture capital firm based in Beijing, China. The firm also has invested in private equity opportunities. It seeks to make investments in sectors such as advanced manufacturing, cutting-edge technology, and the healthcare industries.

Contact Information

Year Founded
2011
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Unit 1907, Block E1, Oriental Plaza
  • No. 1 East Chang'an Street, Dongcheng District
  • Beijing
  • China
+86 010 0000 0000

Delian Capital Investments (67)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
D1 Medical Technology 14-Oct-2021 Early Stage VC 000.00 Drug Discovery Generating Revenue
0000000 16-Jul-2021 00000 00000 0000 Database Software Generating Revenue
00000000 0000000 12-Jul-2021 00000 00000 000.00 Drug Discovery Generating Revenue
0000000 000 11-Jul-2021 00000 00000 Therapeutic Devices Generating Revenue
000000000 00000000 05-Jul-2021 00000 00000 000.00 General Purpose Semiconductors Generating Revenue
00000000000 18-Jun-2021 00000 00000 Computers, Parts and Peripherals Generating Revenue
0000 0000 00000 06-May-2021 00000 00000 000.00 Automation/Workflow Software Generating Revenue
0000000 0000000000 15-Apr-2021 00000 00000 Electronic Equipment and Instruments Generating Revenue
Zhishan Weixin 09-Feb-2021 Early Stage VC Drug Discovery Product Development
Zhishan Weixin 09-Feb-2021 Secondary Transaction - Private 00.00 Drug Discovery Product Development
You’re viewing 10 of 67 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Delian Capital Exits (9)

Company Name Exit Date Exit Type Exit Size
Venus Medtech 10-Dec-2019 IPO 00000
000000000 12-Mar-2019 000000000000000000
000000 00000 00000 08-May-2018 000 000.00
0000000 000 000000 13-Jul-2017 000000000000000000 00000
00000000000 21-Jul-2016 000000000000000000 00000
000000000 06-Apr-2016 000
Esafenet 30-Sep-2014 Merger/Acquisition 000.00
Recida Therapeutics Out of Business
You’re viewing 8 of 9 exits. Get the full list »

Delian Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Delian Capital Team (3)

Name Title Deals Funds Boards Office
Quan Li Founding Partner Beijing, China
Yangzhi Jiang Partner Beijing, China
Guobao Zhao Senior Vice President 0 0 Beijing, China
To view Delian Capital’s complete team members history, request access »

Delian Capital Co-Investors (102)

Name With Exits Lead Partner Series Industry
Emerging Technology Partners 2 Series chart Industry bar
Kaitai Capital 0 0 Series chart Industry bar
Legend Star 0 Series chart Industry bar
Matrix Partners China 0 0 Series chart Industry bar
ZhenFund 0 Series chart Industry bar
You’re viewing 5 of 102 co-investors. Get the full list »